Arcturus Therapeutics's total assets for Q4 2024 were $344.07M, a decrease of -7.17% from the previous quarter. ARCT total liabilities were $103.09M for the fiscal quarter, a -5.24% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.